Open-Label Observation of Addition of Etanercept Versus a Conventional Disease-Modifying Antirheumatic Drug in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy in the Latin American Region

Title
Open-Label Observation of Addition of Etanercept Versus a Conventional Disease-Modifying Antirheumatic Drug in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy in the Latin American Region
Authors
Keywords
-
Journal
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
Volume 20, Issue 1, Pages 25-33
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-12-19
DOI
10.1097/rhu.0000000000000055

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now